Publications by authors named "Simon Hirschmann"

Claim this Profile
S
Submucosal Injection of the RNA Oligonucleotide GUT-1 in Active Ulcerative Colitis Patients: A Randomized, Double-Blind, Placebo-Controlled Phase 2a Induction Trial.
Raja Atreya, Tanja Kühbacher, Maximilian J Waldner, Simon Hirschmann, Oliver Drvarov

J Crohns Colitis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report of severe constrictive perimyocarditis and ischemic hepatitis in a Crohn's disease patient upon infliximab-induced lupus-like syndrome.
Simon Hirschmann, Sarah Fischer, Entcho Klenske, Katharina Dechant, Jörg H W Distler

Therap Adv Gastroenterol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab.
Sarah Fischer, Sarah Cohnen, Entcho Klenske, Heike Schmitt, Francesco Vitali, Simon Hirschmann

Therap Adv Gastroenterol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful cyclosporin and ustekinumab combination therapy in a patient with severe steroid-refractory ulcerative colitis.
Ingo Ganzleben, Carol Geppert, Lourdes Osaba, Simon Hirschmann, Andreas Nägel

Therap Adv Gastroenterol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Therapy of Crohn's Disease-Associated Pulmonary Necrobiotic Nodules on Ustekinumab Therapy.
Ingo Ganzleben, Simon Hirschmann, Julia Köhler, Florian S Fuchs, Ralf J Rieker

Am J Gastroenterol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline levels of dynamic CD4 T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study.
Clarissa Allner, Michaela Melde, Emily Becker, Friederike Fuchs, Laura Mühl, Simon Hirschmann

BMC Gastroenterol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnification endoscopy with optical chromoendoscopy shows strong correlation with histologic inflammation in patients with inflammatory bowel disease.
Entcho Klenske, Raja Atreya, Arndt Hartmann, Sarah Fischer, Simon Hirschmann

Endosc Int Open· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn's disease.
Heike Schmitt, Ulrike Billmeier, Walburga Dieterich, Timo Rath, Sophia Sonnewald, Simon Hirschmann

Gut· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative analysis of articular bone in large cohort of patients with chronic inflammatory diseases of the joints, the gut and the skin.
David Simon, Arnd Kleyer, Matthias Englbrecht, Fabian Stemmler, Christoph Simon, Simon Hirschmann

Bone· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative Colitis.
Caroline J Voskens, Anika Fischer, Susanne Roessner, Carmen Lorenz, Simon Hirschmann

Inflamm Bowel Dis· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression Profiles.
Friederike Fuchs, Daniela Schillinger, Raja Atreya, Simon Hirschmann, Sarah Fischer

Front Immunol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Top-down approach to biological therapy of Crohn's disease.
Simon Hirschmann, Markus F Neurath

Expert Opin Biol Ther· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo.
Anika Fischer, Sebastian Zundler, Raja Atreya, Timo Rath, Caroline Voskens, Simon Hirschmann

Gut· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-resolution Quantitative Computed Tomography Demonstrates Structural Defects in Cortical and Trabecular Bone in IBD Patients.
Judith Haschka, Simon Hirschmann, Arnd Kleyer, Matthias Englbrecht, Francesca Faustini

J Crohns Colitis· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Brain Imaging Reveals Rapid Blockade of Abdominal Pain Response Upon Anti-TNF Therapy in Crohn's Disease.
Andreas Hess, Julie Roesch, Marc Saake, Marina Sergeeva, Simon Hirschmann

Gastroenterology· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclosporine A regulates pro-inflammatory cytokine production in ulcerative colitis.
Stefanie Steiner, Carolin Daniel, Anika Fischer, Imke Atreya, Simon Hirschmann

Arch Immunol Ther Exp (Warsz)· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modern diagnosis of celiac disease and relevant differential diagnoses in the case of cereal intolerance.
Markus Hahn, Alexander F Hagel, Simon Hirschmann, Caroline Bechthold, Peter Konturek

Allergo J Int· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis